Harvard, 10x accuse NanoString of infringing gene sequencing tech

Harvard College and 10x Genomics have sued Nanostring Technologies, alleging that the company’s CosMx imaging platform infringes two patents covering “gene-mapping” technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

More on this story

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

More on this story

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

Harvard, 10x accuse NanoString of infringing gene sequencing tech

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features